Document is current
Any future updates will be listed below
-
Authors
Chen, Robert
Petrazzini, Ben Omega
Duffy, Áine
Rocheleau, Ghislain
Jordan, Daniel
Bansal, Meena
Do, Ron
-
Funding
Funding for this research was provided by:
National Institute of General Medical Sciences (T32-GM007280, R35-GM124836)
- License Information
-
More Information
Article History
Received: 8 July 2024
Accepted: 26 February 2025
First Online: 10 March 2025
Declarations
:
: In all three biobanks accessed in this study (UK Biobank, All of Us, BioMe), participants voluntarily enrolled and gave informed electronic consent. We accessed UK Biobank data under application ID 16218 and All of Us data (Controlled Tier version 7) under workspace aou-rw-75979bcb. The Institutional Review Board at the Icahn School of Medicine at Mount Sinai approved BioMe access (GCO no. 07–0529; STUDY-11–01139).
: R.D. reported being a scientific co-founder, consultant and equity holder for Pensieve Health (pending) and being a consultant for Variant Bio and Character Bio. M.B. receives grant support from Pfizer and Histoindex and serves as a consultant for Madrigal, Intercept, Fibronostics, NOVONordisk, GSK, and The Kinetix Group. All other authors have no competing interests to disclose.
